The impact of the bedside check of medication appropriateness (BED-CMA) at the hematology ward: a mixed-methods study

Langebrake C, Admiraal R, van Maarseveen E, et al. Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55(1):62–9. https://doi.org/10.1038/s41409-019-0538-9.

Article  PubMed  Google Scholar 

Vasu S. Cellular therapies: hematology and beyond. Semin Hematol. 2023;60(1):1–2. https://doi.org/10.1053/j.seminhematol.2023.03.001.

Article  PubMed  Google Scholar 

Andrick B, Tusing L, Jones LK, et al. The impact of a hematopoietic cellular therapy pharmacist on clinical and humanistic outcomes: a RE-AIM framework analysis. Transplant Cell Ther. 2022;28(6):334.e331-334.e339. https://doi.org/10.1016/j.jtct.2022.02.015.

Article  Google Scholar 

Visacri MB, Tavares MG, Barbosa CR, et al. Clinical pharmacy in onco-hematology and bone marrow transplant: a valuable contribution to improving patient safety. J Oncol Pharm Pract. 2021;27(5):1172–80. https://doi.org/10.1177/1078155220943964.

Article  PubMed  Google Scholar 

Reynolds G, Sim B, Anderson MA, et al. Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: a systematic scoping review and narrative synthesis. Clin Microbiol Infect. 2023;29(10):1280–8. https://doi.org/10.1016/j.cmi.2023.05.011.

Article  CAS  PubMed  Google Scholar 

Farias TF, Aguiar KD, Rotta I, et al. Implementing a clinical pharmacy service in hematology. Einstein. 2016;14(3):384–90. https://doi.org/10.1590/s1679-45082016ao3667.

Article  PubMed  PubMed Central  Google Scholar 

Chen PZ, Wu CC, Huang CF. Clinical and economic impact of clinical pharmacist intervention in a hematology unit. J Oncol Pharm Pract. 2020;26(4):866–72. https://doi.org/10.1177/1078155219875806.

Article  CAS  PubMed  Google Scholar 

Moukafih B, Abahssain H, Mrabti H, et al. Impact of clinical pharmacy services in a hematology/oncology ward in Morocco. J Oncol Pharm Pract. 2021;27(2):305–11. https://doi.org/10.1177/1078155220919169.

Article  PubMed  Google Scholar 

Eishy Oskuyi A, Sharifi H, Asghari R. Medication errors in hematology-oncology ward by consultation: the role of the clinical pharmacologist. Casp J Intern Med. 2021;12(1):53–8. https://doi.org/10.22088/cjim.12.1.53.

Article  Google Scholar 

Oliveira CS, Silva MP, Miranda ÍK, et al. Impact of clinical pharmacy in oncology and hematology centers: a systematic review. J Oncol Pharm Pract. 2021;27(3):679–92. https://doi.org/10.1177/1078155220976801.

Article  PubMed  Google Scholar 

Saccardi R, McGrath E, Snowden JA. JACIE accreditation of HSCT programs. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. Cham (CH): Springer; 2019. p. 35–40.

Chapter  Google Scholar 

Horák P, Peppard J, Sýkora J, et al. EAHP European Statements baseline survey 2015: results. Eur J Hosp Pharm. 2016;23(2):69–75. https://doi.org/10.1136/ejhpharm-2016-000889.

Article  PubMed  PubMed Central  Google Scholar 

Skalafouris C, Blanc AL, Grosgurin O, et al. Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists. Int J Clin Pharm. 2023;45(2):406–13. https://doi.org/10.1007/s11096-022-01505-5.

Article  PubMed  Google Scholar 

Vélez-Díaz-Pallarés M, Pérez-Menéndez-Conde C, Bermejo-Vicedo T. Systematic review of computerized prescriber order entry and clinical decision support. Am J Health Syst Pharm. 2018;75(23):1909–21. https://doi.org/10.2146/ajhp170870.

Article  PubMed  Google Scholar 

Roumeliotis N, Sniderman J, Adams-Webber T, et al. Effect of electronic prescribing strategies on medication error and harm in hospital: a systematic review and meta-analysis. J Gen Intern Med. 2019;34(10):2210–23. https://doi.org/10.1007/s11606-019-05236-8.

Article  PubMed  PubMed Central  Google Scholar 

Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. https://doi.org/10.1136/bmj.m3216.

Article  PubMed  PubMed Central  Google Scholar 

Nabovati E, Vakili-Arki H, Taherzadeh Z, et al. Information technology-based interventions to improve drug-drug interaction outcomes: a systematic review on features and effects. J Med Syst. 2017;41(1):12. https://doi.org/10.1007/s10916-016-0649-4.

Article  PubMed  Google Scholar 

Becker ML, Baypinar F, Pereboom M, et al. The effect of medication related clinical decision support at the time of physician order entry. Int J Clin Pharm. 2021;43(1):137–43. https://doi.org/10.1007/s11096-020-01121-1.

Article  CAS  PubMed  Google Scholar 

van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47. https://doi.org/10.1197/jamia.M1809.

Article  PubMed  PubMed Central  Google Scholar 

Genco EK, Forster JE, Flaten H, et al. Clinically inconsequential alerts: the characteristics of opioid drug alerts and their utility in preventing adverse drug events in the emergency department. Ann Emerg Med. 2016;67(2):240-248.e243. https://doi.org/10.1016/j.annemergmed.2015.09.020.

Article  PubMed  Google Scholar 

Villa Zapata L, Subbian V, Boyce RD, et al. Overriding drug-drug interaction alerts in clinical decision support systems: a scoping review. Stud Health Technol Inform. 2022;290:380–4. https://doi.org/10.3233/shti220101.

Article  PubMed  Google Scholar 

Quintens C, De Rijdt T, Van Nieuwenhuyse T, et al. Development and implementation of “check of medication appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance. BMC Med Inform Decis Mak. 2019;19(1):29. https://doi.org/10.1186/s12911-019-0748-5.

Article  PubMed  PubMed Central  Google Scholar 

Quintens C, De Coster J, Van der Linden L, et al. Impact of check of medication appropriateness (CMA) in optimizing analgesic prescribing: an interrupted time series analysis. Eur J Pain. 2021;25(3):704–13. https://doi.org/10.1002/ejp.1705.

Article  PubMed  Google Scholar 

Quintens C, Peetermans WE, Lagrou K, et al. The effectiveness of check of medication appropriateness for antimicrobial stewardship: an interrupted time series analysis. J Antimicrob Chemother. 2021. https://doi.org/10.1093/jac/dkab364.

Article  PubMed  Google Scholar 

Quintens C, Verhamme P, Vanassche T, et al. Improving appropriate use of anticoagulants in hospitalised patients: a pharmacist-led check of medication appropriateness intervention. Br J Clin Pharmacol. 2022;88(6):2959–68. https://doi.org/10.1111/bcp.15184.

Article  PubMed  Google Scholar 

Rommers MK, Zegers MH, De Clercq PA, et al. Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event. Qual Saf Health Care. 2010;19(6):e35. https://doi.org/10.1136/qshc.2009.033704.

Article  CAS  PubMed  Google Scholar 

Rommers MK, Zwaveling J, Guchelaar HJ, et al. Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice. Artif Intell Med. 2013;59(1):15–21. https://doi.org/10.1016/j.artmed.2013.04.001.

Article  PubMed  Google Scholar 

Ibáñez-Garcia S, Rodriguez-Gonzalez C, Escudero-Vilaplana V, et al. Development and evaluation of a clinical decision support system to improve medication safety. Appl Clin Inform. 2019;10(3):513–20. https://doi.org/10.1055/s-0039-1693426.

Article  PubMed  PubMed Central  Google Scholar 

Van De Sijpe G, Hublou W, Declercq P, et al. Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: a proof-of-concept study at the trauma surgery ward. Comput Struct Biotechnol J. 2023;22:58–65. https://doi.org/10.1016/j.csbj.2023.10.017.

Article  PubMed  Google Scholar 

Maertens J, Cesaro S, Maschmeyer G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2397–404. https://doi.org/10.1093/jac/dkw157.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif